165 related articles for article (PubMed ID: 6268296)
21. Vindesine. A phase II trial in advanced breast cancer patients.
Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
[TBL] [Abstract][Full Text] [Related]
22. Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusion.
Ohnuma T; Greenspan EM; Holland JF
Cancer Treat Rep; 1980 Jan; 64(1):25-30. PubMed ID: 6929728
[TBL] [Abstract][Full Text] [Related]
23. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
[TBL] [Abstract][Full Text] [Related]
24. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
Wander HE; Nagel GA
Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
[TBL] [Abstract][Full Text] [Related]
25. Vindesine in the treatment of malignant mesothelioma: a phase II study.
Kelsen D; Gralla R; Cheng E; Martini N
Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
[TBL] [Abstract][Full Text] [Related]
26. Vindesine for metastatic malignant melanoma. A phase II trial.
Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
[TBL] [Abstract][Full Text] [Related]
27. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
28. [Phase-II-study with vindesine (desacetyl-vinblastine-amide-sulfate) in advanced malignant diseases].
Goldhirsch A; Beer M; Sonntag RW; Tschopp L; Cavalli F; Ryssel HJ; Brunner KW
Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1063-7. PubMed ID: 7423151
[TBL] [Abstract][Full Text] [Related]
29. Phase I and pharmacokinetic study of anhydrovinblastine every 3 weeks in patients with refractory solid tumors.
Ramnath N; Schwartz GN; Smith P; Bong D; Kanter P; Berdzik J; Creaven PJ
Cancer Chemother Pharmacol; 2003 Mar; 51(3):227-30. PubMed ID: 12655441
[TBL] [Abstract][Full Text] [Related]
30. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
[TBL] [Abstract][Full Text] [Related]
31. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
Furnas BE; Williams SD; Einhorn LH; Cobleigh MA
Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347
[TBL] [Abstract][Full Text] [Related]
32. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
[TBL] [Abstract][Full Text] [Related]
33. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
[TBL] [Abstract][Full Text] [Related]
34. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
Saiers JH; Slavik M; McKinney DR
Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
[No Abstract] [Full Text] [Related]
35. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of vindesine in patients with squamous cell cancer of the head and neck.
Sledge GW; Clark GM; Griffin C; Mattox DE; Von Hoff DD
Am J Clin Oncol; 1984 Jun; 7(3):209-11. PubMed ID: 6731343
[TBL] [Abstract][Full Text] [Related]
37. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
38. Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion.
Yap HY; Blumenschein GR; Bodey GP; Hortobagyi GN; Buzdar AU; DiStefano A
Cancer Treat Rep; 1981; 65(9-10):775-9. PubMed ID: 7273012
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of vindesine in adenocarcinoma of the lung.
Sledge GW; Clark GM; Von Hoff DD
Cancer Treat Rep; 1984 Mar; 68(3):557-8. PubMed ID: 6704986
[No Abstract] [Full Text] [Related]
40. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
